COMP <GO>
CLVT vs NVDA // GROSS PROFIT MARGIN
Clarivate Plc (NYSE) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: CLVT 2
— NVDA 9
▲ GROSS PROFIT MARGIN LEADER: NVDA
LAST: $1.72 (-2.27%) • MKT CAP: $1.10B
gross-margins
66.00%
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
gross-margins
74.67%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLVT VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLVT | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 66.00% | 74.67% | -8.67 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.30% | 65.06% | -63.76 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.6x | 23.2x | -20.61 | CLVT | /valuation <GO> |
| Free Cash Flow Yield | — | 2.58% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 2.90% | 65.21% | -62.31 | NVDA | /operating-margins <GO> |
| Net Profit Margin | -8.20% | 63.66% | -71.86 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | 83.38% | -87.38 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 19.52 | -19.32 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | CLVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 51.1 | -10.00 | NVDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 2.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.10B | $5.15T | -$5.15T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLVT REV | NVDA REV | CLVT GROSS % | NVDA GROSS % | CLVT FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $2.46B | $130.50B | 66.0% | 75.0% | $365.3M | $60.85B |
| FY 2024 | $2.56B | $60.92B | 66.0% | 72.7% | $357.5M | $27.02B |
| FY 2023 | $2.63B | $26.97B | — | 56.9% | $744.2M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLVT // BETA —
NVDA // BETA 2.04